AR052457A1 - Pirazolil acilsulfonamidas como inhibidores de la enzima convertidora de endotelina utiles en el tratamiento de enfermedad obstructiva cronica pulmonar - Google Patents

Pirazolil acilsulfonamidas como inhibidores de la enzima convertidora de endotelina utiles en el tratamiento de enfermedad obstructiva cronica pulmonar

Info

Publication number
AR052457A1
AR052457A1 ARP060100147A ARP060100147A AR052457A1 AR 052457 A1 AR052457 A1 AR 052457A1 AR P060100147 A ARP060100147 A AR P060100147A AR P060100147 A ARP060100147 A AR P060100147A AR 052457 A1 AR052457 A1 AR 052457A1
Authority
AR
Argentina
Prior art keywords
alkyl
optionally substituted
halogen
alkoxy
heteroaryl
Prior art date
Application number
ARP060100147A
Other languages
English (en)
Spanish (es)
Inventor
Andrew Baxter
Sarah King
Austen Pimm
Chris Luckhurst
Mark Furber
James Reuberson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR052457A1 publication Critical patent/AR052457A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP060100147A 2005-01-13 2006-01-13 Pirazolil acilsulfonamidas como inhibidores de la enzima convertidora de endotelina utiles en el tratamiento de enfermedad obstructiva cronica pulmonar AR052457A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0500105 2005-01-13

Publications (1)

Publication Number Publication Date
AR052457A1 true AR052457A1 (es) 2007-03-21

Family

ID=36677916

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100147A AR052457A1 (es) 2005-01-13 2006-01-13 Pirazolil acilsulfonamidas como inhibidores de la enzima convertidora de endotelina utiles en el tratamiento de enfermedad obstructiva cronica pulmonar

Country Status (3)

Country Link
AR (1) AR052457A1 (fr)
TW (1) TW200637826A (fr)
WO (1) WO2006075955A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200838515A (en) * 2007-02-09 2008-10-01 Takeda Pharmaceutical Fused ring compound
US12030879B2 (en) 2018-03-02 2024-07-09 Inflazome Limited Sulfonyl acetamides as NLRP3 inhibitors
WO2019166632A1 (fr) 2018-03-02 2019-09-06 Inflazome Limited Nouveaux composés
EP3759078A1 (fr) 2018-03-02 2021-01-06 Inflazome Limited Nouveaux composés
WO2019166627A1 (fr) 2018-03-02 2019-09-06 Inflazome Limited Nouveaux composés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11511133A (ja) * 1995-08-02 1999-09-28 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗薬
EP0885890A1 (fr) * 1996-02-26 1998-12-23 Sumitomo Pharmaceuticals Company, Limited Derives de sulfonylureidopyrazole
CA2315614C (fr) * 1999-07-29 2004-11-02 Pfizer Inc. Pyrazoles

Also Published As

Publication number Publication date
TW200637826A (en) 2006-11-01
WO2006075955A1 (fr) 2006-07-20

Similar Documents

Publication Publication Date Title
PE20090617A1 (es) Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa
ES2531256T3 (es) Amidas fungicidas
AR052457A1 (es) Pirazolil acilsulfonamidas como inhibidores de la enzima convertidora de endotelina utiles en el tratamiento de enfermedad obstructiva cronica pulmonar
ATE337000T1 (de) Pyrrolidin-1,2-dicarbonsäure-1- (4-ethinyl- phenyl)-amidö-2- (phenyl)-amidö derivate als inhibitoren der koagulationsfaktoren xa und viia zur behandlung von thrombosen
EA201000145A1 (ru) Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида
DK1720872T3 (da) Aryl- og heteroarylpiperidincarboxylatderivater, fremstilling og anvendelse deraf i form af FAAH-enzyminhibitorer
PE20051136A1 (es) Derivados de sulfonamida
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
AR041250A1 (es) Derivados de sulfonamida como inhibidores de enzimas convertidoras de tnf-alfa
PE20091408A1 (es) Compuestos y composiciones como inhibidores de cinasa
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
ATE385767T1 (de) Körperpflegezusammensetzungen mit salzen von mit dihydroxypropyltri(c1-c3alkyl) ammonium monosubstituierten polyolen
PE20090641A1 (es) Amidas heterociclicas
DE502005009922D1 (de) Faltbare intravasal einführbare blutpumpe
AR056536A1 (es) Compuestos de 2-amino-5- [4-(difluormetoxi)fenil]-5-fenilimidazolona como inhibidores de la beta secretasa (bace)
ATE489370T1 (de) Herstellung und verwendung von verbindungen als aspartylproteasehemmer
ATE405553T1 (de) Heterocyclische verbindungen als inhibitoren von faktor viia
PE20141674A1 (es) Derivados de heterociclos biciclicos para el tratamiento de la hipertension arterial pulmonar
ATE370124T1 (de) Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptase
CY1107846T1 (el) Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες
AR049699A1 (es) Derivados de pirimidina
AR057433A1 (es) Compuestos quimicos derivados de piridopirimidina, un metodo para su preparacion y composicion farmaceutica
ES2258642T3 (es) Derivados de piperidina utiles como moduladores de la actividad del receptor de quimiocina.
AR054688A1 (es) Alquil-piridinas como inhibidores 11-beta de la diabetes
DE602006001590D1 (de) 7-(2-(4-(3-trifluormethylphenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isochinolin-besylatsalz, dessen herstellung und dessen therapeutische verwendung

Legal Events

Date Code Title Description
FA Abandonment or withdrawal